281 related articles for article (PubMed ID: 17561538)
1. Successful treatment of recalcitrant restless legs syndrome with botulinum toxin type-A.
Rotenberg JS; Canard K; Difazio M
J Clin Sleep Med; 2006 Jul; 2(3):275-8. PubMed ID: 17561538
[TBL] [Abstract][Full Text] [Related]
2. Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the association of RLS and obstructive sleep apneas.
Delgado Rodrigues RN; Alvim de Abreu E Silva Rodrigues AA; Pratesi R; Krieger J
Sleep Med; 2006 Apr; 7(3):235-9. PubMed ID: 16564217
[TBL] [Abstract][Full Text] [Related]
3. Restless legs syndrome in end-stage renal disease.
Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
[TBL] [Abstract][Full Text] [Related]
4. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
[TBL] [Abstract][Full Text] [Related]
5. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
Cuellar NG; Ratcliffe SJ
Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
[TBL] [Abstract][Full Text] [Related]
6. Restless legs syndrome (RLS) with expansion of symptoms to the face.
Buchfuhrer MJ
Sleep Med; 2008 Jan; 9(2):188-90. PubMed ID: 17638589
[TBL] [Abstract][Full Text] [Related]
7. [Effect of high dose pergolide mesilate on restless legs syndrome associated with Parkinson disease].
Imamura A; Tsuboi Y; Tanaka M; Obata T; Yamada T
Rinsho Shinkeigaku; 2007 Apr; 47(4):156-9. PubMed ID: 17511286
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
9. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
[TBL] [Abstract][Full Text] [Related]
10. Validation of an algorithm for the diagnosis of Restless Legs Syndrome: The Restless Legs Syndrome-Diagnostic Index (RLS-DI).
Benes H; Kohnen R
Sleep Med; 2009 May; 10(5):515-23. PubMed ID: 18823819
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity in restless legs syndrome among a sample of Swedish adults.
Ulfberg J; Bjorvatn B; Leissner L; Gyring J; Karlsborg M; Regeur L; Skeidsvoll H; Polo O; Partinen M;
Sleep Med; 2007 Nov; 8(7-8):768-72. PubMed ID: 17825613
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort.
Winkelman JW; Finn L; Young T
Sleep Med; 2006 Oct; 7(7):545-52. PubMed ID: 16740407
[TBL] [Abstract][Full Text] [Related]
13. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
14. Validation of the "L-DOPA test" for diagnosis of restless legs syndrome.
Stiasny-Kolster K; Kohnen R; Möller JC; Trenkwalder C; Oertel WH
Mov Disord; 2006 Sep; 21(9):1333-9. PubMed ID: 16705685
[TBL] [Abstract][Full Text] [Related]
15. Empirical evaluation of the accuracy of diagnostic criteria for Restless Legs Syndrome.
Benes H; von Eye A; Kohnen R
Sleep Med; 2009 May; 10(5):524-30. PubMed ID: 18996741
[TBL] [Abstract][Full Text] [Related]
16. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
Sahai A; Dowson C; Khan MS; Dasgupta P
BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
[TBL] [Abstract][Full Text] [Related]
17. Can botulinum toxin put the restless legs syndrome to rest?
Lim EC; Seet RC
Med Hypotheses; 2007; 69(3):497-501. PubMed ID: 17363179
[TBL] [Abstract][Full Text] [Related]
18. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
[TBL] [Abstract][Full Text] [Related]
19. Restless legs syndrome in Parkinson's disease.
Gómez-Esteban JC; Zarranz JJ; Tijero B; Velasco F; Barcena J; Rouco I; Lezcano E; Lachen MC; Jauregui A; Ugarte A
Mov Disord; 2007 Oct; 22(13):1912-6. PubMed ID: 17579369
[TBL] [Abstract][Full Text] [Related]
20. Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS.
Kushida CA; Allen RP; Atkinson MJ
Sleep Med; 2004 Sep; 5(5):485-8. PubMed ID: 15341894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
